BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23508075)

  • 21. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD.
    Avila MP; Farah ME; Santos A; Kapran Z; Duprat JP; Woodward BW; Nau J
    Retina; 2009 Feb; 29(2):157-69. PubMed ID: 19202425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central and pericentral retinal sensitivity after macular translocation surgery.
    Chieh JJ; Stinnett SS; Toth CA
    Retina; 2008; 28(10):1522-9. PubMed ID: 18827740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significant improvements in near vision, reading speed, central visual field and related quality of life after ranibizumab treatment of wet age-related macular degeneration.
    Frennesson C; Nilsson UL; Peebo BB; Nilsson SE
    Acta Ophthalmol; 2010 Jun; 88(4):420-5. PubMed ID: 19678811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study.
    Michels S; Rosenfeld PJ; Puliafito CA; Marcus EN; Venkatraman AS
    Ophthalmology; 2005 Jun; 112(6):1035-47. PubMed ID: 15936441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
    Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
    Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bevacizumab for neovascular age-related macular degeneration in China.
    Li X; Hu Y; Sun X; Zhang J; Zhang M;
    Ophthalmology; 2012 Oct; 119(10):2087-93. PubMed ID: 22818896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 16 and 24 Gy low-voltage X-ray irradiation with ranibizumab therapy for neovascular age-related macular degeneration: 12-month outcomes.
    Morales-Canton V; Quiroz-Mercado H; Velez-Montoya R; Zavala-Ayala A; Moshfeghi AA; Shusterman EM; Kaiser PK; Sanislo SR; Gertner M; Moshfeghi DM
    Am J Ophthalmol; 2013 Jun; 155(6):1000-1008.e2. PubMed ID: 23497847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of retinal sensitivity to ranibizumab treatment of macular edema after acute branch retinal vein occlusion.
    Mylonas G; Sacu S; Dunavoelgyi R; Matt G; Blum R; Buehl W; Pruente C; Schmidt-Erfurth U;
    Retina; 2013 Jun; 33(6):1220-6. PubMed ID: 23584689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifocal pupillography identifies ranibizumab-induced changes in retinal function for exudative age-related macular degeneration.
    Sabeti F; Maddess T; Essex RW; James AC
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):253-60. PubMed ID: 22159011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: results up to 7 years.
    van Zeeburg EJ; Maaijwee KJ; Missotten TO; Heimann H; van Meurs JC
    Am J Ophthalmol; 2012 Jan; 153(1):120-7.e2. PubMed ID: 21907969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
    Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
    Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of OCT characteristics and retinal sensitivity in neovascular age-related macular degeneration in the course of monthly ranibizumab treatment.
    Sulzbacher F; Kiss C; Kaider A; Roberts P; Munk M; Kroh ME; Sayegh R; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1310-5. PubMed ID: 23349430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the siRNA PF-04523655 versus ranibizumab for the treatment of neovascular age-related macular degeneration (MONET Study).
    Nguyen QD; Schachar RA; Nduaka CI; Sperling M; Klamerus KJ; Chi-Burris K; Yan E; Paggiarino DA; Rosenblatt I; Aitchison R; Erlich SS;
    Ophthalmology; 2012 Sep; 119(9):1867-73. PubMed ID: 22683252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 16-Gy low-voltage x-ray irradiation with ranibizumab therapy for AMD: 6-month safety and functional outcomes.
    Canton VM; Quiroz-Mercado H; Velez-Montoya R; Lopez-Miranda MJ; Moshfeghi AA; Shusterman EM; Kaiser PK; Sanislo SR; Gertner M; Moshfeghi DM
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):468-73. PubMed ID: 21830747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyes.
    Baek JS; Cho HJ; Cho SW; Kim CG; Kim JW
    Retina; 2013 Mar; 33(3):467-73. PubMed ID: 23400082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphologic and functional evaluation before and after successful macular hole surgery using spectral-domain optical coherence tomography combined with microperimetry.
    Chen WC; Wang Y; Li XX
    Retina; 2012 Oct; 32(9):1733-42. PubMed ID: 22466479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.
    Stangos AN; Gandhi JS; Nair-Sahni J; Heimann H; Pournaras CJ; Harding SP
    Am J Ophthalmol; 2010 Nov; 150(5):666-73. PubMed ID: 20719300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma.
    Mason JO; Albert MA; Persaud TO; Vail RS
    Retina; 2007 Sep; 27(7):903-7. PubMed ID: 17891015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery of the neurosensory retina after macular translocation surgery is independent of preoperative macular sensitivity in neovascular age-related macular degeneration.
    Mettu PS; Sarin N; Stinnett SS; Toth CA
    Retina; 2011 Sep; 31(8):1637-49. PubMed ID: 21775925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.
    Yamaike N; Tsujikawa A; Sakamoto A; Ota M; Kotera Y; Miyamoto K; Kita M; Yoshimura N
    Retina; 2009 Jun; 29(6):757-67. PubMed ID: 19289982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.